ESPE Abstracts

ESPE Abstracts

Published by BioScientifica
Previous issue | Volume 89 | ESPE2018 | Next issue

57th Annual ESPE (ESPE 2018)

Athens, Greece
27 Sept 2018 - 29 Sept 2018

Card image cap
ESPE 2018 57th European Society for Paediatric Endocrinology Annual Meeting 27-29 September 2018 Athens, Greece

Poster Presentations

Diabetes & Insulin P3

Previous section
Diabetes & Insulin P2
Table of contents
Next section
Fat, Metabolism and Obesity P1

hrp0089p3-p071 | Diabetes & Insulin P3

Multiple Autoimmune Association and Varied Spectrum of Presentation in Indian Diabetic Children

hrp0089p3-p072 | Diabetes & Insulin P3

Severe Hypertriglyceridemia and Multiple Autoimmune Phenomenon at new onset Type 1 DM

hrp0089p3-p073 | Diabetes & Insulin P3

Effects of Diabetes Mellitus Type-1 on Vitamin D Status Among Children

hrp0089p3-p074 | Diabetes & Insulin P3

Association between Prior Toxic Stressors and Development of T2DM in Adolescents

hrp0089p3-p075 | Diabetes & Insulin P3

First Four Cases of Neonatal Diabetes from Kazakhstan, Almaty with Proven Mutations in KCNJ11 and INS Genes

hrp0089p3-p076 | Diabetes & Insulin P3

First 2 Cases of Monogenic Diabetes (MODY) from Kazakhstan, Almaty with Proven Heterozygous Mutation in Hepatocyte Nuclear Factor 1-Alpha (HNF1A) Gene

hrp0089p3-p077 | Diabetes & Insulin P3

Achievement of Therapy Targets in Children and Adolescents with Type 1 Diabetes Mellitus at the ‘Diabetes School’

hrp0089p3-p078 | Diabetes & Insulin P3

Characteristics of MODY-GCK Diabetes in Children and Adolescents in Siberia

hrp0089p3-p079 | Diabetes & Insulin P3

Clinical Case of MODY-GCK Diabetes: Heterogeneity of Course among Relatives from One Family

hrp0089p3-p080 | Diabetes & Insulin P3

Clinical and Biochemical Characteristics of Familial Type 1 Diabetes Mellitus (FT1DM) Compared to Non-Familial Type 1 DM (T1DM)

hrp0089p3-p081 | Diabetes & Insulin P3

Prevalence of Beta-cell Antibodies and Associated Autoimmune Diseases in Children and Adolescents with Type 1 (T1DM) vs Type 2 Diabetes Mellitus (T2DM) in Qatar

hrp0089p3-p082 | Diabetes & Insulin P3

Clinical Presentation and Autoimmune Markers in Children and Adolescents with Familial Type 1 Diabetes Mellitus (FT1DM) and Familial Type 2 Diabetes Mellitus (FT2DM)

hrp0089p3-p083 | Diabetes & Insulin P3

Real–world Clinical Evolution of Type 1 Diabetes Patients on Twenty Years

hrp0089p3-p084 | Diabetes & Insulin P3

Diabetic Capilaropathy: A Case Report

hrp0089p3-p085 | Diabetes & Insulin P3

A Sibling Case of Wolfram Syndrome with Diabetes Mellitus Diagnosed within 10 Months in Early Childhood

hrp0089p3-p086 | Diabetes & Insulin P3

Continuous Subcutaneous Insulin Infusion in Children and Adolescents: Analysis of Initial and Follow Up Basal Rates

hrp0089p3-p087 | Diabetes & Insulin P3

Prevalance of Fatty Liver in Patients with Type 1 Diabetes Mellitus Attending Diabetes Clinic at Alexandria University Children’s Hospital

hrp0089p3-p088 | Diabetes & Insulin P3

The Triad of Obesity, Acanthosis Nigricans and Diabetes Mellitus in a Newly Diagnosed Adolescent; Is This Type 1 Or Type 2 Diabetes Mellitus?

hrp0089p3-p089 | Diabetes & Insulin P3

A Female Patient with Atypical Diabetes Features, Showing Heterozygous Mutations on G6PC2 (Glucose 6 Phosphatase, Catalytic Subunit 2): Does Explain All Clinical Manifestations or Is It Only Polymorphism?

hrp0089p3-p090 | Diabetes & Insulin P3

Clinical and Laboratory Features at the Onset of Childhood Type 1 Diabetes Mellitus in the Nortwest Region (Trakya) of Turkey

hrp0089p3-p091 | Diabetes & Insulin P3

Clinical and Epidemiological Features of Children with Type 1 Diabetes

hrp0089p3-p092 | Diabetes & Insulin P3

Predictors of Optimal Glycemic Control in Children with Diabetes Mellitus Type 1 Receiving Pump Insulin Therapy

hrp0089p3-p093 | Diabetes & Insulin P3

Symptomatic Cerebral Infarction: A Rare Complication of Diabetic Ketoacidosis

hrp0089p3-p094 | Diabetes & Insulin P3

Our Clinical Experiences in Type 2 Diabetes

hrp0089p3-p095 | Diabetes & Insulin P3

The Relationship between Serum Levels of C-Peptide and the Age, BMI, and Insülin Doses in Reply to: Newly Diagnosed Type 1 Diabetic Children

hrp0089p3-p096 | Diabetes & Insulin P3

Serum Trace Element Levels in Children Presenting with Diabetic Ketozis and Diabetic Ketoacidosis: A Longitudinal Controlled Study

hrp0089p3-p097 | Diabetes & Insulin P3

Evaluation of Relation between Diabetic Education Levels of Type 1 DM Child/Adolescent and Parents and Metabolic Control

hrp0089p3-p098 | Diabetes & Insulin P3

A Case of Childhood Type 1 Diabetes Mellitus Who Developed Granuloma Annulare

hrp0089p3-p099 | Diabetes & Insulin P3

Case Report: De Novo Mutation of Foxp3 Causing Mild Phenotype of Immunodysregulation, Polyendocrinopathy, Enteropathy, X-Link Syndrome

hrp0089p3-p100 | Diabetes & Insulin P3

Is There a Relationship between Immune-Mediated Type 1 Diabetes Mellitus and Congenital Rubella Infection?

hrp0089p3-p101 | Diabetes & Insulin P3

Changes in Glycemic Control after Switching from NPH & RI to Insulin Glargine and Lispro in Children with Type 1 Diabetes Mellitus (T1DM)

hrp0089p3-p102 | Diabetes & Insulin P3

When Type Mody Ii Diabetes Simulates Type I Diabetes

hrp0089p3-p103 | Diabetes & Insulin P3

Epidemiological Study and Analysis of Type 1 Diabetes Comparing Patients with and Without Ketoacidosis in the Last 5 Years

hrp0089p3-p104 | Diabetes & Insulin P3

The Frequency of Diabetic Ketoacidosis Hospitalization in Siberian Children and Adolescent

hrp0089p3-p105 | Diabetes & Insulin P3

Monogenic Diabetes Cause by Mutation of the Gene HNF–1A

hrp0089p3-p106 | Diabetes & Insulin P3

Reversibility of Early Acute Diabetic Neuropathy (DN) in Adolescents with Type 1 Diabetes Mellitus (T1D)

hrp0089p3-p107 | Diabetes & Insulin P3

The Value of Continuous Hemodiafiltration in Rescuing Children with Severe Diabetic Ketoacidosis

hrp0089p3-p108 | Diabetes & Insulin P3

Psychosocial Risks, Comorbidities and Health Events During the Follow-up of Children and Adolescents with Type 1 Diabetes

hrp0089p3-p109 | Diabetes & Insulin P3

Clinical Profile and Outcome of Diabetic Ketoacidosis in a Tertiary Care Teaching Hospital of a Developing Country

hrp0089p3-p110 | Diabetes & Insulin P3

Diabetes Mellitus, Autoimmune Hemolytic Anemia, Hepatosplenomegaly and Lymphadenopathy: A Rare Association in Chinese Children

hrp0089p3-p111 | Diabetes & Insulin P3

Type 1 Diabetes and Central Precocious Puberty a Rare Association

hrp0089p3-p112 | Diabetes & Insulin P3

Diabetic Ketoacidosis among Egyptian Children with Type 1 Diabetes: 3-Years Study

hrp0089p3-p113 | Diabetes & Insulin P3

Fructosamine Level in Type 1 Diabetes Mellitus Children Performing Ramadhan Fasting

hrp0089p3-p114 | Diabetes & Insulin P3

Metformin Therapy Ina Lean Adolescent Girl with Prediabetes Dysglycemia Treated: Good Response

hrp0089p3-p115 | Diabetes & Insulin P3

Association between Thyroid Stimulating Hormone and Hemoglobine A1c in Type 1 Diabetes Mellitus Children

hrp0089p3-p116 | Diabetes & Insulin P3

Monogenic Diabetes in 2 Years and 4 Months Old Girl: Is it DEND?

hrp0089p3-p117 | Diabetes & Insulin P3

Compliance for Monitoring of Glycemic Control in Children with Type 1 Diabetes

hrp0089p3-p118 | Diabetes & Insulin P3

Ketogenic Diet in a Child with Diabetes and Global Developmental Delay

hrp0089p3-p119 | Diabetes & Insulin P3

A Rare Cause of Severe Anemia in a Patient with Type 1 Diabetes

hrp0089p3-p120 | Diabetes & Insulin P3

Oral Gliclazide (A Sulfonylurea) Monotherapy is Effective and Safe in the Management of T2DM in Children: A Case Report

hrp0089p3-p121 | Diabetes & Insulin P3

Pediatric Stroke as the Presenting Symptom of New Onset Diabetes without DKA

hrp0089p3-p122 | Diabetes & Insulin P3

Challenges in Educating New Onset Type 1 Diabetes Mellitus Patients: Can the Use of a Tablet be the Answer?

hrp0089p3-p123 | Diabetes & Insulin P3

AID-GM System (Advanced Intelligent Distant – Glucose Monitoring) to Monitor Health Status and Metabolic Control of Young People with Type 1 Diabetes

hrp0089p3-p124 | Diabetes & Insulin P3

Continuous Glucose Monitoring Results of Our Cases with MODY Type 2 Diabetes

hrp0089p3-p399 | Diabetes & Insulin P3

Family Investigation and Clinical Phenotype Analysis of Type A Insulin Resistance Syndrome

hrp0089p3-p403 | Diabetes & Insulin P3

Epidemiology, Demographic Criteria and Risk Factors in Type 1 DM Egyptian Children; A Single Center Study

hrp0089p3-p407 | Diabetes & Insulin P3

Degludec Versus Glargine in Pediatric and Adolescent Patients with Type 1 Diabetes

hrp0089p3-p416 | Diabetes & Insulin P3

A Rare and Unexpected Cause of Diabetes in Childhood

hrp0089p3-p417 | Diabetes & Insulin P3

Study of Children with Type 1 Diabetes Mellitus of Long Duration Attending Alexandria University Children’S Hospital

hrp0089p3-p419 | Diabetes & Insulin P3

Abstract unavailable

Published by BioScientifica

ESPE Abstracts

© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more